Glioblastoma Multiforme Treatment News and Information

What is Glioblastoma Multiforme? (Definition)

According to the National Cancer Institute, Glioblastoma multiforme is a fast-growing type of central nervous system tumor that forms from glial (supportive) tissue of the brain and spinal cord and has cells that look very different from normal cells. Glioblastoma multiforme usually occurs in adults and affects the brain more often than the spinal cord. Also called GBM, glioblastoma, and grade IV astrocytoma.

See below for updated news and information regarding Glioblastoma Multiforme including new medical research, treatment options and advancements. 

Latest Glioblastoma Multiforme Treatment News and Research

Glioblastoma Treatment News: Researchers discover potential new target for treating glioblastoma

(SOURCE: UT SOUTHWESTERN MEDICAL CENTER) - Scientists have found a way to inhibit the growth of glioblastoma, a type of brain cancer with low survival rates, by targeting a protein that drives growth of brain tumors, according to research from the Peter O'Donnell Jr. Brain Institute and Harold C. Simmons Comprehensive Cancer Center. "These findings change our fundamental understanding of the molecular ...
Read More

Brain Cancer Treatment News: Malaria drug successfully treats 26-year-old brain cancer patient

(SOURCE: UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS) -  After her brain cancer became resistant to chemotherapy and then to targeted treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a few months to live. Now a paper published January 17 in the journal eLife describes a new drug combination that has stabilized Rosendahl’s disease and increased both the quantity and quality ...
Read More

Glioblastoma Treatment News: TGen identifies compound that could improve drug development against brain cancer

(SOURCE: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE) - ATA prevents glioblastoma from spreading, and leaves cancer vulnerable to chemotherapy and radiation. A study led by scientists at the Translational Genomics Research Institute (TGen) has identified "a potent inhibitory compound" in the elusive hunt for an improved treatment against glioblastoma, the most common and deadly type of adult brain cancer. Aurintricarboxylic Acid (ATA) is ...
Read More

Glioblastoma Treatment News: TUMOR-SEEKING SALMONELLA TREATS BRAIN TUMORS

(SOURCE: DUKE UNIVERSITY) - Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer -- a strain of salmonella that usually causes food poisoning. Clinicians sorely need new treatment approaches for glioblastoma, the most aggressive form of brain cancer. The blood-brain barrier -- a protective sheath separating brain tissue from its ...
Read More

Glioblastoma Treatment News: Suppressing repair protein could be key to treating brain tumors

(SOURCE: UNIVERSITY OF LEEDS) - Targeting a specific DNA-repairing protein in the brain could be an effective way to treat the most aggressive type of brain tumor, a study suggests. Researchers at the University of Leeds found that inhibiting this protein, called RAD51, helped increase the effectiveness of radiotherapy in killing off glioblastoma cells in the lab. Glioblastoma is the most common ...
Read More

Glioblastoma Treatment News: Immunotherapy, Gene Therapy Combination Shows Promise Against Glioblastoma

(SOURCE: UNIVERSITY OF MICHIGAN HEALTH SYSTEM) - In a new study, gene therapy deployed with immune checkpoint inhibitors demonstrates potential benefit for devastating brain cancer. “Devastating” and “dismal.” That’s how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months. New research out of the University of ...
Read More

Glioblastoma Multiforme Treatment News: New Treatment for Glioblastoma Multiforme Developed by NFCR Scientists

(SOURCE: NATIONAL FOUNDATION FOR CANCER RESEARCH) - NFCR congratulates Dr. Web Cavenee and Dr. Paul B. Fisher on their discovery of a new pharmacological agent to treat glioblastoma multiforme (GBM), the deadliest brain cancer, which they have been developing together with NFCR support ...
Read More

Glioblastoma Treatment News: Some glioblastoma patients benefit from ‘ineffective’ treatment

(SOURCE: STANFORD UNIVERSITY MEDICAL CENTER) - Glioblastoma patients with a high degree of vascularization of their tumors were found to have benefited from a treatment previously deemed ineffective, a new Stanford study shows. A subgroup of patients with a devastating brain tumor called glioblastoma multiforme benefited from treatment with a class of chemotherapy drugs that two previous large clinical trials indicated was ...
Read More

Glioblastoma Treatment News: Direct-To-Brain Chemo Better than Systemic Drugs When Immunotherapy Is to Follow

(SOURCE: JOHNS HOPKINS MEDICINE) - In experiments on mice with a form of aggressive brain cancer, Johns Hopkins researchers have shown that localized chemotherapy delivered directly to the brain rather than given systemically may be the best way to keep the immune system intact and strong when immunotherapy is also part of the treatment. The researchers say their study results, reported Dec ...
Read More

Glioblastoma Research News: Dartmouth researchers break new territory analyzing DNA modifications in Glioblastoma

(DARTMOUTH-HITCHCOCK MEDICAL CENTER) According to a recent press release, using state-of-the-art molecular biology and statistical approaches, researchers at Dartmouth's Norris Cotton Cancer Center (NCCC) have identified the functional role of two distinct DNA modifications in glioblastoma (GBM) tissues. The signature of one of these pattern disruptions in particular, 5hmC, had a particularly strong association with patient survival ...
Read More
Loading...